As HIV Has Evolved, Dolutegravin Has Become Less Effective In Sub-Saharan Africa

Dolutegravir, the HIV wonder drug and current first-line treatment, is less effective in sub-Saharan Africa, and the reason is as old as evolution itself- mutation.  As HIV copies itself and replicates, its genetic code (RNA) can change. While a drug may i ...

Article - News Staff - Dec 1 2020 - 7:30pm